C11H19N7O9, orthorhombic, P212121 (no. 19), a = 6.2578(2) Å, b = 15.4188(5) Å, c = 17.6841(7) Å, V = 1706.30(1) Å3, Z = 4, Rgt(F) = 0.0428, wRref(F2) = 0.0972, T = 100 K
In the crystal structure of the title compound [systematic name: 1-methylpiperazine-1,4-diium bis(...
C6HN9O6, orthorhombic, Pbca (no. 61), a = 10.5199(19) Å, b = 13.436(3) Å, c = 15.235(3) Å, V = 2153....
C2H6O⋅C6H6N2O⋅C7H6O4, triclinic, P1̄ (no. 2), a = 7.4217(18) Å, b = 7.7021(18) Å, c = 15.362(4) Å, α...
C6H12O4N4, monoclinic, Cc (no. 9), a = 9.8171(4) Å, b = 16.1119(6) Å, c = 6.9125(5) Å, β = 121.443°,...
C22H15N3O2, triclinic, P1‾$P‾{1}$ (no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) ...
C17H16N2O8, monoclinic, P21/c (no. 14), a = 7.0825(4) Å, b = 15.6168(9) Å, c = 15.1086(9) Å, β = 93....
C14H8Br2N4O6⋅2(C2H6OS), triclinic, P1‾$P\bar{1}$ (no. 2), a = 6.1463(12) Å, b = 8.3637(16) Å, c = 12...
C18H22N4O6, triclinic, P1̄ (no. 2), a = 5.03050(10) Å, b = 12.4151(4) Å, c = 15.5353(5) Å, α = 96.18...
Tzvetkov NT, Peeva MI, Tsakovska I, Milella L, Pajeva I, Stammler H-G. The crystal structure of (4SR...
C8H8N2O4, monoclinic, C2/c (no. 15) , a = 27.748(5) Å, b = 5.6488(10) Å, c = 16.437(3) Å, β = 93.393...
C8H13N5O5, triclinic, P1̄ (no. 2), a = 9.1462(4) Å, b = 9.9732(5) Å, c = 13.5252(6) Å, α = 90.098(2)...
C6H5N11O6, monoclinic, P21/n (no. 14), a = 13.463(5) Å, b = 6.526(2) Å, c = 14.068(5) Å, β = 95.96...
C15H11N3O2, triclinic, P1̄ (no. 2), a = 8.4680(5) Å, b = 9.7578(5) Å, c = 10.2101(6) Å, α = 104.578(...
C30H44N2O4Sn2, monoclinic, P21/c, a = 8.8810(8) Å, b = 16.8999(13) Å, c = 10.5705(10) Å, β = 92.0460...
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.88...
In the crystal structure of the title compound [systematic name: 1-methylpiperazine-1,4-diium bis(...
C6HN9O6, orthorhombic, Pbca (no. 61), a = 10.5199(19) Å, b = 13.436(3) Å, c = 15.235(3) Å, V = 2153....
C2H6O⋅C6H6N2O⋅C7H6O4, triclinic, P1̄ (no. 2), a = 7.4217(18) Å, b = 7.7021(18) Å, c = 15.362(4) Å, α...
C6H12O4N4, monoclinic, Cc (no. 9), a = 9.8171(4) Å, b = 16.1119(6) Å, c = 6.9125(5) Å, β = 121.443°,...
C22H15N3O2, triclinic, P1‾$P‾{1}$ (no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) ...
C17H16N2O8, monoclinic, P21/c (no. 14), a = 7.0825(4) Å, b = 15.6168(9) Å, c = 15.1086(9) Å, β = 93....
C14H8Br2N4O6⋅2(C2H6OS), triclinic, P1‾$P\bar{1}$ (no. 2), a = 6.1463(12) Å, b = 8.3637(16) Å, c = 12...
C18H22N4O6, triclinic, P1̄ (no. 2), a = 5.03050(10) Å, b = 12.4151(4) Å, c = 15.5353(5) Å, α = 96.18...
Tzvetkov NT, Peeva MI, Tsakovska I, Milella L, Pajeva I, Stammler H-G. The crystal structure of (4SR...
C8H8N2O4, monoclinic, C2/c (no. 15) , a = 27.748(5) Å, b = 5.6488(10) Å, c = 16.437(3) Å, β = 93.393...
C8H13N5O5, triclinic, P1̄ (no. 2), a = 9.1462(4) Å, b = 9.9732(5) Å, c = 13.5252(6) Å, α = 90.098(2)...
C6H5N11O6, monoclinic, P21/n (no. 14), a = 13.463(5) Å, b = 6.526(2) Å, c = 14.068(5) Å, β = 95.96...
C15H11N3O2, triclinic, P1̄ (no. 2), a = 8.4680(5) Å, b = 9.7578(5) Å, c = 10.2101(6) Å, α = 104.578(...
C30H44N2O4Sn2, monoclinic, P21/c, a = 8.8810(8) Å, b = 16.8999(13) Å, c = 10.5705(10) Å, β = 92.0460...
C6H9N3O3, monoclinic, P21/n (no. 14), a = 9.5584(4) Å, b = 6.7828(3) Å, c = 12.8337(6) Å, β = 103.88...
In the crystal structure of the title compound [systematic name: 1-methylpiperazine-1,4-diium bis(...
C6HN9O6, orthorhombic, Pbca (no. 61), a = 10.5199(19) Å, b = 13.436(3) Å, c = 15.235(3) Å, V = 2153....
C2H6O⋅C6H6N2O⋅C7H6O4, triclinic, P1̄ (no. 2), a = 7.4217(18) Å, b = 7.7021(18) Å, c = 15.362(4) Å, α...
DOI
Add to ORKG